Comparison of treatment effect of fixed and non-fixed interval prescription of Actinomycin-D on ß-HCG level among patients with low-grade gestational trophoblastic neoplasia
Phase 2
Recruiting
- Conditions
- Trophoblastic neoplasia.Hydatidiform mole, unspecified
- Registration Number
- IRCT201706199014N170
- Lead Sponsor
- Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 76
Inclusion Criteria
Age of 16 to 50 years; low-grade gestational trophoblastic neoplasia; no response to methotrexate.
Exclusion criteria: Pregnancy or breastfeeding; history of herpes or chicken Pox infection; liver or kidney or bone marrow disorder.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measuring the serum level ß-HCG. Timepoint: before intervention and every week for 1 month and then monthly for 3 months and then every 2 months for 6 months. Method of measurement: through laboratory test.
- Secondary Outcome Measures
Name Time Method